05-1564 Sigma-AldrichAnti-mTOR Antibody, clone 21A12.2
Detect mTOR using this Anti-mTOR Antibody, clone 21A12.2 validated for use in WB & IC.
More>> Detect mTOR using this Anti-mTOR Antibody, clone 21A12.2 validated for use in WB & IC. Less<<Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
Species Reactivity | Key Applications | Host | Format | Antibody Type |
---|---|---|---|---|
H | WB, ICC | M | Purified | Monoclonal Antibody |
References |
---|
Product Information | |
---|---|
Format | Purified |
Control |
|
Presentation | Purified mouse monoclonal in buffer containing 0.1 M Tris-Glycine (pH7.4), 150 mM NaCl, with 0.05% sodium azide. |
Quality Level | MQ100 |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Storage and Shipping Information | |
---|---|
Storage Conditions | Stable for 1 year at 2-8ºC from date of receipt. |
Packaging Information | |
---|---|
Material Size | 100 µg |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
05-1564 | 04053252402548 |
Documentation
Licencias necesarias
Título |
---|
PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD |
Anti-mTOR Antibody, clone 21A12.2 Ficha datos de seguridad (MSDS)
Título |
---|
Anti-mTOR Antibody, clone 21A12.2 Certificados de análisis
Cargo | Número de lote |
---|---|
Anti-mTOR, clone 21A12.2 | 2476749 |
Anti-mTOR, clone 21A12.2 - 2376018 | 2376018 |
Anti-mTOR, clone 21A12.2 - 2000824 | 2000824 |
Anti-mTOR, clone 21A12.2 - 2278558 | 2278558 |
Anti-mTOR, clone 21A12.2 - 3204243 | 3204243 |
Anti-mTOR, clone 21A12.2 - 3273620 | 3273620 |
Anti-mTOR, clone 21A12.2 - 3323746 | 3323746 |
Anti-mTOR, clone 21A12.2 - 3660411 | 3660411 |
Anti-mTOR, clone 21A12.2 - 3852337 | 3852337 |
Anti-mTOR, clone 21A12.2 - 4112558 | 4112558 |
Folleto
Cargo |
---|
Advancing cancer research: From hallmarks & biomarkers to tumor microenvironment progression |